Gewebebanken

A. Pruß; U. Kalus; J. Schroeter

doi:10.1055/s-0035-1558116

Transfusionsmedizin, Table of Contents

Transfusionsmedizin 2015; 5(04): 175-185
DOI: 10.1055/s-0035-1558116

Übersicht

Georg Thieme Verlag KG Stuttgart · New York

Gewebebanken

Tissue Banking

Authors

A. Pruß

Universitätsgewebebank, Institut für Transfusionsmedizin, Charité – Universitätsmedizin Berlin, Berlin
U. Kalus

Universitätsgewebebank, Institut für Transfusionsmedizin, Charité – Universitätsmedizin Berlin, Berlin
J. Schroeter

Universitätsgewebebank, Institut für Transfusionsmedizin, Charité – Universitätsmedizin Berlin, Berlin

Abstract

Zusammenfassung

Die allogene Gewebetransplantation umfasst im Wesentlichen die Übertragung von Augenhornhaut, muskuloskelettalen und kardiovaskulären Geweben. Die entsprechenden Indikationen decken eine hohe Bandbreite von unterschiedlichen Gewebedefekten ab und sind therapeutischer Standard. Gewebebanken haben in Anlehnung an die Logistik der Transfusionsmedizin ein Sicherheitsstufenkonzept etabliert, welches aus Spenderauswahl, Labortestung sowie Gewebegewinnung und -verarbeitung besteht. Die zugrunde liegenden Herstellungsverfahren sollen einerseits die biologischen Eigenschaften des Gewebes schützen und andererseits zu einer hohen Infektionssicherheit führen. In Deutschland werden hierfür Antibiotikabehandlungen sowie validierte chemische und thermische Inaktivierungsverfahren mit Erfolg angewendet. Qualitätssichernde Maßnahmen gemäß AMWHV und TPG-Gewebe-Verordnung sichern die gesetzeskonforme Arbeit von Gewebebanken ab.

Abstract

The allogenic tissue transplantation comprises basically the application of corneal, musculoskeletal and cardiovascular tissue preparations. The clinical indications cover a high range of different tissue defects and are part of many therapeutic procedures. In comparison to the standards of transfusion medicine tissue banks have set up a safety concept which consists of clinical history, laboratory testing and validated manufacturing procedures. These procedures should protect the biological properties of the tissue and avoid the transmission of infectious diseases. In Germany antibiotic treatments as well as validated chemical and thermal inactivation methods are applied for this successfully. Quality assurance according to AMWHV and TPG-GewV guarantee the law-compliant work.

Schlüsselwörter

Gewebebank - Tissue Banking - Inaktivierungsmaßnahmen - Infektionsserologie - Gewebetransplantation

Key words

tissue bank - inactivation - infectious serology - tissue transplantation - quality assurance

Full Text

References

Literatur
1 Schilling-Leiß D, Witt F, Tönjes RR. [Report on notifications according to section 8 d of the German Transplantation Act (TPG) for the years 2009–2011]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2014; 57: 111-127
2 Bundesministerium der Justiz und für Verbraucherschutz. Gesetz über Qualität und Sicherheit von menschlichen Geweben und Zellen (Gewebegesetz) vom 20. Juli 2007. BGBl. I: 1574.
3 European Union. Directive 2004/23/EC of the European Parliament and of the Council of 31 March 2004 on setting standards of quality and safety for the donation, procurement, testing, processing, preservation, storage and distribution of human tissues and cells. Official Journal of the European Union 07.04.2004; 102: 48-58
4 European Union. Commission Directive 2006/17/EC of 8 February 2006 implementing Directive 2004/23/EC of the European Parliament and of the Council as regards certain technical requirements for the donation, procurement and testing of human tissues and cells. Official Journal of the European Union 09.02.2006; 38: 40-52
5 European Union. Commission Directive 2006/86/EC of 24 October 2006 implementing Directive 2004/23/EC of the European Parliament and of the Council as regards traceability requirements, notification of serious adverse reactions and events and certain technical requirements for the coding, processing, preservation, storage and distribution of human tissues and cells. Official Journal of the European Union 25.10.2006; 294: 32-50
6 Bundesgesetzblatt. Verordnung über die Anforderungen an Qualität und Sicherheit der Entnahme von Geweben und deren Übertragung nach dem Transplantationsgesetz (TPG-Gewebeverordnung – TPG-GewV). Fassung vom 26. März 2008. BGBl I 1998; 512
7 Hangody L, Füles P. Autologous osteochondral mosaicplasty for the treatment of full-thickness defects of weight bearing joints. Ten years of experimental and clinical experience. J Bone Joint Surg Br 2003; 85?A: 25-32
8 Gudas R, Kalesinskas RJ, Kimtys V et al. A prospective randomized clinical study of mosaic osteochondral autologous transplantation versus microfracture for the treatment of osteochondral defects in the knee joint in young athletes. Arthroscopy 2005; 21: 1066-1075
9 Guettler JH, Demetropoulos CK, Yang KH et al. Dynamic evaluation of contact pressure and the effects of graft harvest with subsequent lateral release at osteochondral donor sites in the knee. Arthroscopy 2005; 21: 715-720
10 Coons DA, Barber FA. Arthroscopic osteochondral autografting. Orthop Clin North Am 2005; 36: 447-458
11 Peterson L, Minas T, Brittberg M et al. Treatment of osteochondritis dissecans of the knee with autologous chondrocyte transplantation: results at two to ten years. J Bone Joint Surg Am 2003; 85?A: 17-24
12 Knutsen G, Drogset JO, Engebretsen L et al. A randomized trial comparing autologous chondrocyte implantation with microfracture. Findings at five years. J Bone Joint Surg Am 2007; 89: 2105-2112
13 Horas U, Pelinkovic D, Herr G et al. Autologous chondrocyte implantation and osteochondral cylinder transplantation in cartilage repair of the knee joint. A prospective, comparative trial. J Bone Joint Surg Am 2003; 85?A: 185-192
14 Peters G, Wirth CJ. The current state of meniscal allograft transplantation and replacement. Knee 2003; 10: 19-31
15 Verdonk PC, Verstraete KL, Almqvist KF et al. Meniscal allograft transplantation: long-term clinical results with radiological and magnetic resonance imaging correlations. Knee Surg Sports Traumatol Arthrosc 2006; 14: 694-706
16 Pinczewski LA, Deehan DJ, Salmon LJ. A five year comparison of patellar tendon four-strand hamstring tendon for arthroscopic reconstruction of the anterior cruciate ligament. Am J Sports Med 2002; 30: 523-536
17 Robke M, Becker R, Urbach D et al. [Semitendinosus tendon versus patellar ligament. Results of a prospective, randomized study after anterior cruciate ligament reconstruction]. Unfallchirurg 2001; 104: 312-316
18 Eriksson K, Anderberg P, Hamberg P et al. There are differences in early morbidity after ACL reconstruction when comparing patellar tendon and semitendinosus tendon graft. A prospective randomized study of 107 patients. Scand J Med Sci Sports 2001; 11: 170-177
19 Järvelä T, Kannus P, Järvinen M. Anterior knee pain 7 years after an anterior cruciate ligament reconstruction with a bone-patellar tendon-bone autograft. Scand J Med Sci Sports 2000; 10: 221-227
20 Barrett G, Stokes G, White M. Anterior cruciate ligament reconstruction in patients older than 40 years: allograft versus autograft patellar tendon. Am J Sports Med 2005; 33: 505-509
21 Bright RW, Green WT. Freeze-dried fascia lata allografts: a review of 47 cases. J Pediatr Orthop 1981; 1: 13-22
22 Maculé F, Segur JM, Vilalta C et al. The use of fascia lata and bone allograft for uncontained defects in revision knee arthroplasty. Ann Transplant 2004; 9: 72-83
23 Sikka RS, Neault M, Guanche CA. Reconstruction of the pectoralis major tendon with fascia lata allograft. Orthopedics 2005; 28: 1199-1201
24 Steenvoorde P, Van Doorn LP, Brehm V et al. Use of a cadaveric donor fascia lata in a patient with an open knee joint following necrotising fasciitis. J Wound Care 2007; 16: 115-117
25 Ackermann W, Taillard W. Transplantation von konservierter, homogener Spongiosa. Z Orthop 1977; 115: 679-686
26 Ascherl R, Morgalla M, Geissdörfer K et al. Experimentelle Untersuchungen und klinische Aspekte zur Kältekonservierung allogener Spongiosa. Orthopäde 1986; 15: 22-29
27 Urist MR, Strates B. Bone morphogenetic proteins. J Dent Res 1971; 50: 1392-1406
28 Hallfeldt KKJ, Kessler S, Puhlmann M et al. Der Einfluss verschiedener Sterilisationsverfahren auf die osteoinduktiven Eigenschaften demineralisierter Knochenmatrix. Unfallchirurg 1992; 95: 313-318
29 Starker M, Kandziora F, Jäger A et al. Pfannenrekonstruktion mit Pfannenstützschalen. Orthopäde 1998; 27: 366-374
30 Bavetta G, Licata ME. The use of human allogenic graft (HBA) for maxillary bone regeneration: review of literature and case reports. Curr Pharm Des 2012; 18: 5559-5568
31 Azuma T, Yasuda H, Okagaki K et al. Compressed allograft chips for acetabular reconstruction in revision hip arthroplasty. J Bone Joint Surg Br 1994; 76: 740-744
32 Perka C, Fink B, Millrose M et al. Revisionsendoprothetik. In: Claes L, Kirschner P, Perka C, Rudert M, Hrsg. AE-Manual der Endoprothetik. Heidelberg: Springer; 2012: 441-588
33 Muscolo DL, Ayerza MA, Calabrese ME et al. The use of a bone allograft for reconstruction after resection of giant-cell tumor close to the knee. J Bone Joint Surg Am 1993; 75: 1656-1662
34 Knop C, Blauth M, Bühren V et al. Operative Behandlung von Verletzungen des thorakolumbalen Übergangs Teil 2: Operation und röntgenologische Befunde. Unfallchirurg 2000; 103: 1032-1047
35 Ganz R, Klaue K, Vinh TS et al. A new periacetabular osteotomy for the treatment of hip dysplasias. Clin Orthop 1988; 232: 26-36
36 Putzier M, Strube P, Funk JF et al. Allogenic versus autologous cancellous bone in lumbar segmental spondylodesis: a randomized prospective study. Eur Spine J 2009; 18: 687-695
37 Krocker D, Matziolis G, Pruss A et al. Reconstruction of the extensor mechanism using a free, allogenic, freeze-dried patellar graft. Unfallchirurg 2007; 110: 563-566
38 Boack DH, Manegold S, Haas NP. [Surgical technique for talus fractures. Tips and tricks]. Unfallchirurg 2004; 107: 515-520
39 Pruss A, Perka C, Degenhardt P et al. Clinical efficacy and compatibility of allogeneic avital tissue transplants sterilized with a peracetic acid/ethanol mixture. Cell Tissue Bank 2002; 3: 235-243
40 Maier P, Reinhard T. Keratoplasty: laminate or penetrate? Part 1: penetrating keratoplasty. Ophthalmologe 2009; 106: 563-569
41 Maier P, Reinhard T, Cursiefen C. Descemet stripping endothelial keratoplasty–rapid recovery of visual acuity. Dtsch Arztebl Int 2013; 110: 365-371
42 Melles GR, Ong TS, Ververs B et al. Descemet membrane endothelial keratoplasty (DMEK). Cornea 2006; 25: 987-990
43 Reinshagen H, Boehringer D, Seitz B et al. [Activities of the tissue transplantation and biotechnology section of the German Ophthalmological Society: 4. Performance report 2013]. Ophthalmologe 2015; 112: 70-72
44 Barratt-Boyes BG. Homograft aortic valve replacement in aortic incompetence and stenosis. Thorax 1964; 19: 131
45 Ross DN. Homograft replacement of the aortic valve. Lancet 1962; 2: 487
46 Ross DN, Sommerville J. Correction of pulmonary atresia with a homograft aortic valve. Lancet 1966; 2: 1446
47 Ross DN. Replacement of aortic and mitral valves with a pulmonary autograft. Lancet 1967; 2: 956-958
48 da Costa FD, Santos LR, Collatusso C et al. Thirteen yearsʼ experience with the Ross Operation. J Heart Valve Dis 2009; 18: 84-94
49 Sabik JF, Lytle BW, Blackstone EH et al. Aortic root replacement with cryopreserved allograft for prosthetic valve endocarditis. Ann Thorac Surg 2002; 74: 650-659
50 Nägele H, Döring V, Rödiger W et al. Aortenklappenersatz mit Homografts. Herz 2000; 27: 651-658
51 Vogt PR, von Segesser LK, Goffin Y et al. Cryopreserved arterial homografts for in situ reconstruction of mycotic aneurysms and prosthetic graft infection. Eur J Cardiothorac Surg 1995; 9: 502-506
52 Pruss A, Meyer R, Knobl HJ et al. Analyse der Tätigkeiten kardiovaskulärer Gewebebanken in Deutschland in den Jahren 2007 bis 2010. Z Herz Thorax Gefäßchir 2012; 26: 214-222
53 Tugwell BD, Patel PR, Williams IT et al. Transmission of hepatitis C virus to several organ and tissue recipients from an antibody-negative donor. Ann Intern Med 2005; 143: 648-654
54 Pruss A, Kao M, Gohs U et al. Effects of gamma irradiation on human cortical bone transplants contaminated with enveloped and non-enveloped viruses. Biologicals 2002; 30: 205-213
55 Pruss A, Caspari G, Krüger DH et al. Nukleinsäure-Amplifikationstests für HIV, HBV und HCV bei Gewebespendern: Sinnvoll oder überflüssig?. Transfus Med Hemother 2008; 35: 421-430
56 Shutkin NM. Homologous-serum hepatitis following the use of refrigerated bone-bank bone. J Bone Joint Surg 1954; 36?A: 160-162
57 Schratt HE, Regel G, Kiesewetter B et al. HIV-Infektion durch kältekonservierte Knochentransplantate. Unfallchirurg 1996; 9: 679-684
58 Centers for Disease Control (CDC). Transmission of HIV through bone transplantation: case report and public health recommendations. MMWR Morb Mortal Wkly Rep 1988; 37: 597-599
59 Hoft RH, Pflugfelder SC, Forster RK et al. Clinical evidence for hepatitis B transmission resulting from corneal transplantation. Cornea 1997; 16: 132-137
60 Simonds RJ, Holmberg SD, Hurwitz RL et al. Transmission of human immunodeficiency virus type 1 from a seronegative organ and tissue donor. N Engl J Med 1992; 326: 726-732
61 Clarke JA. HIV transmission and skin grafts. Lancet 1987; 1: 983
62 Li CM, Ho YR, Liu YC. Transmission of human immunodeficiency virus through bone transplantation: a case report. J Formosan Med Assoc 2001; 100: 350-351
63 Conrad EU, Gretch DR, Obermeyer K et al. Transmission of the hepatitis-C virus by tissue transplantation. J Bone Joint Surg Am 1992; 77: 214-224
64 Eggen BM, Nordbo SA. Transmission of HCV by organ transplantation. N Engl J Med 1992; 326: 411
65 Pereira BJ, Milford EL, Kirkman RL et al. Low risk of liver disease after tissue transplantation from donors with HCV. Lancet 1993; 341: 903-904
66 Morris A, Strickett MG, Barratt-Boyes BG. Use of aortic valve allografts from hepatitis B surface antigen-positive donors. Ann Thorac Surg 1990; 49: 802-805
67 Tomford WW, Starkweather RJ, Goldman MH. A study of the clinical incidence of infection in the use of banked allograft bone. J Bone Joint Surg Am 1981; 63: 244-248
68 Sutherland AG, Raafat A, Yates P et al. Infection associated with the use of allograft bone from the North East Scotland Bone Bank. J Hosp Infect 1997; 35: 215-222
69 Liu JW, Chao LH, Su LH et al. Experience with a bone bank operation and allograft bone infection in recipients at medical centre in southern Taiwan. J Hosp Infect 2002; 50: 293-297
70 Kainer MA, Linden JV, Whaley DN et al. Clostridium infections associated with musculoskeletal-tissue allografts. N Engl J Med 2004; 350: 2564-2571
71 Centers for Disease Control and Prevention (CDC). Update: allograft-associated bacterial infections–United States, 2002. MMWR Morb Mortal Wkly Rep 2002; 51: 207-210
72 Richtlinie zur Gewinnung von Spenderhornhäuten und zum Führen einer Augenhornhautbank. 11. September 2014; BAnz AT 06. 10. 2014 B5.
73 Zou S, Dodd RY, Stramer SL et al. Tissue Safety Study Group. Probability of viremia with HBV, HCV, HIV, and HTLV among tissue donors in the United States. N Engl J Med 2004; 351: 751-759
74 Yao F, Seed C, Farrugia A et al. The risk of HIV, HBV, HCV and HTLV infection among musculoskeletal tissue donors in Australia. Am J Transplant 2007; 7: 2723-2726
75 Pruss A, Caspari G, Krüger DH et al. Tissue donation and virus safety: more nucleic acid amplification testing is needed. Transpl Infect Dis 2010; 12: 375-386
76 Wilkemeyer I, Pruss A, Kalus U et al. Comparative infectious serology testing of pre- and post-mortem blood samples from cornea donors. Cell Tissue Bank 2012; 13: 447-452
77 Edler C, Wulff B, Schröder AS et al. A prospective time-course study on serological testing for human immunodeficiency virus, hepatitis B virus and hepatitis C virus with blood samples taken up to 48 h after death. Med Microbiol 2011; 60: 920-926
78 Kalus U, Wilkemeyer I, Pruss A et al. Validation of serological testing for anti-treponema pallidum from postmortem blood on the Siemens-BEP-III Automatic. Transfus Med Hemother 2013; 40: 403-408
79 Gubbe K, Scharnagl Y, Grosch S et al. Validation of virus NAT for HIV, HCV, HBV and HAV using post-mortal blood samples. Transfus Med Hemother 2012; 39: 381-385
80 Brosig H, Jacker HJ, Borchert HH et al. Sufficient penetration of peracetic acid into drilled human femoral heads. Cell Tissue Bank 2005; 6: 231-237
81 Knaepler H, von Garrel T, Gotzen L. Untersuchungen zur Desinfektion und Sterilisation allogener Knochentransplantate. Hefte Z Unfallchir 1994; 235: 1-101
82 Pruss A, Kao M, von Garrel T et al. Virus inactivation in bone tissue transplants (femoral heads) by moist heat with the ‘Marburg bone bank system’. Biologicals 2003; 31: 75-82
83 Pruss A, Seibold M, Benedix F et al. Validation of the ‘Marburg bone bank system’ for thermodesinfection of allogenic femoral head transplants using selected bacteria, fungi, and spores. Biologicals 2003; 31: 287-294
84 von Versen R, Heider H, Kleemann I et al. Chemische Sterilisation biologischer Implantate mit einer Kombinationsmethode. Osteologie 1992; 7: 380-386
85 Pruss A, Göbel UB, Pauli G et al. Peracetic acid-ethanol treatment of allogeneic avital bone tissue transplants–a reliable sterilization method. Ann Transplant 2003; 8: 34-42
86 Hinton R, Jinnah RH, Johnson C et al. A biomechanical analysis of solvent-dehydrated and freeze-dried human fascia lata allografts. Am J Sports Med 1992; 20: 607-612
87 Günther KP, Scharf HP, Pesch HJ et al. Osteointegration lösungsmittelkonservierter Knochentransplantate im Tiermodell. Osteologie 1996; 5: 4-12
88 Schroeter J, Wilkemeyer I, Schiller RA et al. Validation of the microbiological testing of tissue preparations using the BACTEC™ Blood Culture System. Transfus Med Hemother 2012; 39: 387-390
89 Schroeter J, Maier P, Bednarz J et al. [Procedural guidelines. Good tissue practice for cornea banks]. Ophthalmologe 2009; 106: 265-274